Wall Street
Price Targets

3EE0 Price Targets Summary
Kancera AB

There are no price targets for 3EE0.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kancera AB Competitors:
Price Targets
AZT
Arcticzymes Technologies ASA
49% Upside
ELDN
Eledon Pharmaceuticals Inc
398% Upside
301080
Acrobiosystems Co Ltd
42% Upside
ABOS
Acumen Pharmaceuticals Inc
186% Upside
ORGO
Organogenesis Holdings Inc
52% Upside
688177
Bio-Thera Solutions Ltd
59% Upside

Revenue
Forecast

Revenue Estimate
Kancera AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Kancera AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Kancera AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 3EE0's stock price target?
Not Available

3EE0 doesn't have any price targets made by Wall Street professionals.

Back to Top